Piperidine, 4-(3-methyl-1-azetidinyl)-, trihydrochloride
- Product Code: 51413
CAS:
864441-92-9
| Molecular Weight: | 264 g./mol | Molecular Formula: | C₉H₂₁Cl₃N₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of various active pharmaceutical ingredients (APIs). Its structure makes it a valuable intermediate in the creation of complex molecules, especially those targeting neurological and cardiovascular disorders. Additionally, it is employed in the study of receptor binding and enzyme inhibition, aiding in the discovery of new therapeutic agents. Its trihydrochloride form enhances solubility, making it suitable for use in aqueous-based experimental setups.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.200 | 10-20 days | $452.03 |
+
-
|
Piperidine, 4-(3-methyl-1-azetidinyl)-, trihydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of various active pharmaceutical ingredients (APIs). Its structure makes it a valuable intermediate in the creation of complex molecules, especially those targeting neurological and cardiovascular disorders. Additionally, it is employed in the study of receptor binding and enzyme inhibition, aiding in the discovery of new therapeutic agents. Its trihydrochloride form enhances solubility, making it suitable for use in aqueous-based experimental setups.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :